ASCO

Scoring System Predicts GI Cancer Survival

06/17/2016

JCP Editors

A team of investigators has developed a scoring system that may inform decision-making for the treatment of gastrointestinal neuroendocrine carcinomas. With the scoring system, patients are assigned a score from 0...

A team...

06/17/2016

Journal of Clinical Pathways

Venetoclax Response in Patients With R/R CLL

06/15/2016

JCP Editors

Patients with chronic lymphocytic leukemia (CLL) who are relapsed or refractory (R/R) to ibrutinib or idelalisib may benefit from venetoclax monotherapy, according to a study presented at the 2016 American Society of...

...

06/15/2016

Journal of Clinical Pathways

Significant Cost Variation in Breast Cancer Chemotherapy

06/13/2016

JCP Editors

A study presented at the 2016 American Society of Clinical Oncology Annual Meeting (June 3-7; Chicago, IL) has found that the costs associated with different breast cancer chemotherapy regimens can vary...

A...

06/13/2016

Journal of Clinical Pathways

Conference Coverage

American Society of Clinical Oncology (ASCO) 2016 Annual Meeting

05/31/2016

Its once again time for the American Society of Clinical Oncology (ASCO) Annual Meeting (June 3-7, 2016; Chicago, IL), which will bring together more than 30,000 oncology professionals from around the world to...

Its...

05/31/2016

Journal of Clinical Pathways

Transplant Still Preferred Treatment Choice in Young Patients With Myeloma

05/31/2016

JCP Editors

Autologous stem cell transplantation (ASCT) is still the preferred treatment of choice for patients under the age of 65 years with newly diagnosed multiple myeloma (NDMM), according to early results from a phase 3...

...

05/31/2016

Journal of Clinical Pathways

Research in Review

New ASCO Report Finds Oncologists Concerned About Value-Based Care Initiatives and Alternative Payment Models

03/18/2016

JCP Editors

In its third annual State of Cancer Care in America report, the American Society of Clinical Oncology (ASCO) described a number of the advances and remaining challenges concerning cancer care—including the sudden...

In its...

03/18/2016

Journal of Clinical Pathways

Counterpoint

ASCO Policy Statement on Clinical Pathways in Oncology Represents Great Progress for Clinical Pathways

03/08/2016

Winston Wong , PharmD;

The ASCO Policy Statement on Oncology Clinical Pathways shows how far clinical pathways have come in gaining acceptance among providers and supports their potential for improving the value of cancer care. The...

The...

03/08/2016

Journal of Clinical Pathways

Viewpoint

Greater Alignment Among Oncology Clinical Pathways is Needed

03/08/2016

Edward Stepanski , PhD;

A single, consensus-driven approach to oncology clinical pathways shared across payers appears to be a logical step if these approaches are to be indeed evidence-based and if administrative burden is to be managed...

A...

03/08/2016

Journal of Clinical Pathways

Interview

The ASCO Perspective on Oncology Clinical Pathways

03/08/2016

In the face of rising health care costs, oncology clinical pathways have been well documented as an effective tool for reducing inefficiency and improving quality in cancer care. A 2014 study reviewing 642 patients...

In the...

03/08/2016

Journal of Clinical Pathways

Conference Coverage

2016 American Society of Clinical Oncology Quality Care Symposium

03/08/2016

JCP Editors

A number of recent initiatives have required health care providers to think more proactively about the value of the care they deliver. This is especially true in the treatment of patients with cancer, where...

...

03/08/2016

Journal of Clinical Pathways